Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers

The Measurement of Observer Agreement for Categorical Data

Landis, J. R., & Koch, G. G. (1977) · Biometrics · doi:10.2307/2529310 · Cited by 81,148 · see citing works

Phenotypic Analysis of Antigen-Specific T Lymphocytes

Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (1996) · Science · doi:10.1126/science.274.5284.94 · Cited by 3,544 · cited 1× · see citing works

Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections

Appay, V., Dunbar, P. R., Callan, M. F. C., Klenerman, P., Gillespie, G. M. A., Papagno, L., Ogg, G. S., King, A., Lechner, F., Spina, C. A., et al. (2002) · Nature Medicine · doi:10.1038/nm0402-379 · Cited by 1,556 · see citing works

A Direct Estimate of the Human αβ T Cell Receptor Diversity

Arstila, T. P., Casrouge, A., Baron, V., Even, J., Kanellopoulos, J., & Kourilsky, P. (1999) · Science · doi:10.1126/science.286.5441.958 · Cited by 931 · see citing works

Phenotype and function of human T lymphocyte subsets: Consensus and issues

Appay, V., van Lier, R. A. W., Sallusto, F., & Roederer, M. (2008) · Cytometry Part A · doi:10.1002/cyto.a.20643 · Cited by 729 · see citing works

HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides.

Garboczi, D. N., Hung, D. T., & Wiley, D. C. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3429 · Cited by 693 · see citing works

Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry

Chattopadhyay, P. K., Price, D. A., Harper, T. F., Betts, M. R., Yu, J., Gostick, E., Perfetto, S. P., Goepfert, P., Koup, R. A., De Rosa, S. C., et al. (2006) · Nature Medicine · doi:10.1038/nm1371 · Cited by 372 · see citing works

Design and use of conditional MHC class I ligands

Toebes, M., Coccoris, M., Bins, A. D., Rodenko, B., Gomez, R., Nieuwkoop, N. J., van de Kasteele, W., Rimmelzwaan, G. F., Haanen, J. B. A. G., Ovaa, H., et al. (2006) · Nature Medicine · doi:10.1038/nm1360 · Cited by 348 · see citing works

Generation of peptide–MHC class I complexes through UV-mediated ligand exchange

Rodenko, B., Toebes, M., Hadrup, S. R., van Esch, W. J. E., Molenaar, A. M., Schumacher, T. N., & Ovaa, H. (2006) · Nature Protocols · doi:10.1038/nprot.2006.121 · Cited by 320 · see citing works

Current Status and Future Prospects

Wood, C. E., Baker, G., & Trounson, A. (1984) · Springer eBooks · doi:10.1007/978-1-4471-3317-9_2 · Cited by 306 · see citing works

Inhibition of gap junctional intercellular communication by perfluorinated fatty acids is dependent on the chain length of the fluorinated tail

Upham, B. L., Deocampo, N. D., Wurl, B., & Trosko, J. E. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19981109)78:4 · Cited by 180 · see citing works

Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7

Bakker, A., Hoppes, R., Linnemann, C., Toebes, M., Rodenko, B., Berkers, C. R., Hadrup, S. R., van Esch, W. J. E., Heemskerk, M. H. M., Ovaa, H., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709717105 · Cited by 151 · see citing works

Selective Expansion of Cross-Reactive Cd8+ Memory T Cells by Viral Variants

Haanen, J. B. A. G., Wolkers, M. C., Kruisbeek, A. M., & Schumacher, T. N. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.9.1319 · Cited by 113 · see citing works

Identification of New Melanoma Epitopes on Melanosomal Proteins Recognized by Tumor Infiltrating T Lymphocytes Restricted by HLA-A1, -A2, and -A3 Alleles

Kawakami, Y., Robbins, P. F., Wang, X., Tupesis, J. P., Parkhurst, M. R., Kang, X., Sakaguchi, K., Appella, E., & Rosenberg, S. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.6985 · Cited by 113 · see citing works

Parasite Stage–Specific Recognition of Endogenous Toxoplasma gondii –Derived CD8 + T Cell Epitopes

Frickel, E., Sahoo, N., Hopp, J., Gubbels, M., Craver, M. P. J., Knoll, L. J., Ploegh, H. L., & Grotenbreg, G. M. (2008) · The Journal of Infectious Diseases · doi:10.1086/593019 · Cited by 112 · see citing works

Shared epitopes for HLA-A3-restricted melanoma-reactive human CTL include a naturally processed epitope from Pmel-17/gp100

Skipper, J., Kittlesen, D. J., Hendrickson, R. C., Deacon, D. H., Harthun, N. L., Wagner, S. N., Hunt, D. F., Engelhard, V. H., & Slingluff, C. L. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.11.5027 · Cited by 100 · see citing works

Discovery of CD8 + T cell epitopes in Chlamydia trachomatis infection through use of caged class I MHC tetramers

Grotenbreg, G. M., Roan, N. R., Guillén, E., Meijers, R., Wang, J., Bell, G. W., Starnbach, M. N., & Ploegh, H. L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711504105 · Cited by 73 · see citing works

MHC multimer technology: current status and future prospects

Bakker, A., & Schumacher, T. N. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.06.008 · Cited by 70 · see citing works

The CD8 T-Cell Response against Murine Gammaherpesvirus 68 Is Directed toward a Broad Repertoire of Epitopes from both Early and Late Antigens

Gredmark‐Russ, S., Cheung, E. J., Isaacson, M. K., Ploegh, H. L., & Grotenbreg, G. M. (2008) · Journal of Virology · doi:10.1128/jvi.01463-08 · Cited by 60 · see citing works

On the Role of Melanoma-Specific CD8+ T-Cell Immunity in Disease Progression of Advanced-Stage Melanoma Patients

van Oijen, M., Bins, A. D., Elias, S. G., Sein, J. J., Weder, P., GAST, G. C. D., Mallo, H. A., Gallee, M. P. W., van Tinteren, H., Schumacher, T. N., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0260 · Cited by 52 · see citing works

Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade

McGranahan, N., Furness, A. J. S., Rosenthal, R., Ramskov, S., Lyngaa, R., Saini, S. K., Jamal-Hanjani, M., Wilson, G. A., Birkbak, N. J., Hiley, C. T., et al. (2016) · Science · doi:10.1126/science.aaf1490 · Cited by 3,065 · see citing works

Genomic features of response to combination immunotherapy in patients with advanced non-small-cell lung cancer

Hellmann, M. D., Nathanson, T., Rizvi, H., Creelan, B. C., Sanchez-Vega, F., Ahuja, A., Ni, A., Novik, J. B., Mangarin, L. M. B., Abu-Akeel, M., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.018 · Cited by 1,095 · see citing works

Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

Cossarizza, A., Chang, H., Radbruch, A., Acs, A., Adam, D., Adam‐Klages, S., Agace, W. W., Aghaeepour, N., Akdiş, M., Allez, M., et al. (2019) · European Journal of Immunology · doi:10.1002/eji.201970107 · Cited by 982 · see citing works

Actively personalized vaccination trial for newly diagnosed glioblastoma

Hilf, N., Kuttruff-Coqui, S., Frenzel, K., Bukur, V., Stevanović, S., Gouttefangeas, C., Platten, M., Tabatabai, G., Dutoit, V., van der Burg, S. H., et al. (2019) · Nature · doi:10.1038/s41586-018-0810-y · Cited by 938 · see citing works

Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients

Baitsch, L., Baumgaertner, P., Devêvre, E., Raghav, S. K., Legat, A., Barba, L., Wieckowski, S., Bouzourene, H., Deplancke, B., Romero, P., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46102 · Cited by 845 · see citing works

BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans

Sahin, U., Muik, A., Vogler, I., Derhovanessian, E., Kranz, L. M., Vormehr, M., Quandt, J., Bidmon, N., Ulges, A., Baum, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03653-6 · Cited by 845 · see citing works

Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive Melanoma

van Rooij, N., van Buuren, M. M., Philips, D., Velds, A., Toebes, M., Heemskerk, B., van Dijk, L. J. A., Behjati, S., Hilkmann, H., el Atmioui, D., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.7521 · Cited by 798 · see citing works

Guidelines for the use of flow cytometry and cell sorting in immunological studies *

Cossarizza, A., Chang, H., Radbruch, A., Akdiş, M., Andrä, I., Annunziato, F., Bächer, P., Barnaba, V., Battistini, L., Bauer, W. M., et al. (2017) · European Journal of Immunology · doi:10.1002/eji.201646632 · Cited by 572 · see citing works

Dynamics and specificities of T cells in cancer immunotherapy

Oliveira, G., & Wu, C. (2023) · Nature Reviews. Cancer · doi:10.1038/s41568-023-00560-y · Cited by 495 · see citing works

Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)

Cossarizza, A., Chang, H., Radbruch, A., Abrignani, S., Addo, R., Akdis, M., Andrä, I., Andreata, F., Annunziato, F., Arranz, E., et al. (2021) · European Journal of Immunology · doi:10.1002/eji.202170126 · Cited by 531 · see citing works

Analyzing the Mycobacterium tuberculosis immune response by T-cell receptor clustering with GLIPH2 and genome-wide antigen screening

Huang, H., Wang, C., Rubelt, F., Scriba, T. J., & Davis, M. M. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0505-4 · Cited by 484 · see citing works

Neoantigen landscape dynamics during human melanoma–T cell interactions

Verdegaal, E. M. E., de Miranda, N. F. C. C., Visser, M., Harryvan, T. J., van Buuren, M. M., Andersen, R. S., Hadrup, S. R., van der Minne, C. E., Schotte, R., Spits, H., et al. (2016) · Nature · doi:10.1038/nature18945 · Cited by 464 · see citing works

Targeting of cancer neoantigens with donor-derived T cell receptor repertoires

Strønen, E., Toebes, M., Kelderman, S., van Buuren, M. M., Yang, W., van Rooij, N., Donia, M., Böschen, M.-L., Lund‐Johansen, F., Olweus, J., et al. (2016) · Science · doi:10.1126/science.aaf2288 · Cited by 443 · see citing works

Anti–CTLA-4 therapy broadens the melanoma-reactive CD8 + T cell response

Kvistborg, P., Philips, D., Kelderman, S., Hageman, L., Ottensmeier, C. H. H., Joseph‐Pietras, D., Welters, M. J. P., van der Burg, S., Kapiteijn, E., Michielin, O. A., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008918 · Cited by 378 · see citing works

Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes

Bentzen, A. K., Marquard, A. M., Lyngaa, R., Saini, S. K., Ramskov, S., Donia, M., Such, L., Furness, A. J. S., McGranahan, N., Rosenthal, R., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3662 · Cited by 332 · see citing works

Effector CD4 and CD8 T Cells and Their Role in the Tumor Microenvironment

Hadrup, S. R., Donia, M., & Straten, P. T. (2012) · Cancer Microenvironment · doi:10.1007/s12307-012-0127-6 · Cited by 309 · see citing works

Combinatorial tetramer staining and mass cytometry analysis facilitate T-cell epitope mapping and characterization

Newell, E. W., Sigal, N., Nair, N., Kidd, B. A., Greenberg, H. B., & Davis, M. M. (2013) · Nature Biotechnology · doi:10.1038/nbt.2593 · Cited by 295 · see citing works

Targeting the DNA damage response in immuno-oncology: developments and opportunities

Chabanon, R. M., Rouanne, M., Lord, C. J., Soria, J., Pasero, P., & Postel-Vinay, S. C. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00386-6 · Cited by 300 · see citing works

Adoptive Immunotherapy for Cancer or Viruses

Maus, M. V., Fraietta, J. A., Levine, B. L., Kalos, M. D., Zhao, Y., & June, C. H. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120136 · Cited by 265 · see citing works

Islet-reactive CD8 + T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors

Čulina, S., Lalanne, A. I., Afonso, G., Cerosaletti, K. M., Pinto, S., Sebastiani, G., Kuranda, K., Nigi, L., Eugster, A., Østerbye, T., et al. (2018) · Science Immunology · doi:10.1126/sciimmunol.aao4013 · Cited by 266 · see citing works

NetTCR-2.0 enables accurate prediction of TCR-peptide binding by using paired TCRα and β sequence data

Montemurro, A., Schuster, V., Povlsen, H. R., Bentzen, A. K., Jurtz, V. I., Chronister, W. D., Crinklaw, A., Hadrup, S. R., Winther, O., Peters, B., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02610-3 · Cited by 262 · see citing works

Adoptive T-Cell Therapy Using Autologous Tumor-Infiltrating Lymphocytes for Metastatic Melanoma

Wu, R. C. H., Forget, M., Chacon, J. A., Bernatchez, C., Haymaker, C., Chen, J. Q., Hwu, P., & Radvanyi, L. G. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e31824d4465 · Cited by 248 · see citing works

Glutaminyl cyclase is an enzymatic modifier of the CD47- SIRPα axis and a target for cancer immunotherapy

Logtenberg, M. E. W., Jansen, J. H. M., Raaben, M., Toebes, M., Franke, K., Brandsma, A. M., Matlung, H. L., Fauster, A., Gomez, R., Bakker, N. A. M., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0356-z · Cited by 242 · see citing works

SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8 + T cell activation in COVID-19 patients

Saini, S. K., Hersby, D. S., Tamhane, T., Povlsen, H. R., Hernandez, S. P. A., Nielsen, M., Gang, A. O., & Hadrup, S. R. (2021) · Science Immunology · doi:10.1126/sciimmunol.abf7550 · Cited by 222 · see citing works

The cancer antigenome

Heemskerk, B., Kvistborg, P., & Schumacher, T. N. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.333 · Cited by 229 · see citing works

The Role of Neoantigens in Naturally Occurring and Therapeutically Induced Immune Responses to Cancer

Ward, J. P., Gubin, M. M., & Schreiber, R. D. (2016) · Advances in immunology · doi:10.1016/bs.ai.2016.01.001 · Cited by 228 · see citing works

Simultaneous Detection of Circulating Autoreactive CD8+ T-Cells Specific for Different Islet Cell–Associated Epitopes Using Combinatorial MHC Multimers

Velthuis, J. H. L., Unger, W. W. J., Abreu, J. R. F., Duinkerken, G., Franken, K. L. M. C., Peakman, M., Bakker, A., Hadrup, S. R., Keymeulen, B., Drijfhout, J. W., et al. (2010) · Diabetes · doi:10.2337/db09-1486 · Cited by 202 · see citing works

Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-up

van den Berg, J. H., Heemskerk, B., van Rooij, N., Gomez-Eerland, R., Michels, S., van Zon, M., de Boer, R., Bakker, N. A. M., Jorritsma‐Smit, A., van Buuren, M. M., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-000848 · Cited by 194 · see citing works

Exomics and immunogenics

Champiat, S., Ferté, C., Lebel‐Binay, S., Eggermont, A. M. M., & Soria, J. (2014) · OncoImmunology · doi:10.4161/onci.27817 · Cited by 192 · see citing works

Enumeration of human antigen–specific naive CD8+ T cells reveals conserved precursor frequencies

Alanio, C., Lemaı̂tre, F., Law, H., Hasan, M., & Albert, M. L. (2010) · Blood · doi:10.1182/blood-2009-10-251124 · Cited by 179 · see citing works

TIL therapy broadens the tumor-reactive CD8+T cell compartment in melanoma patients

Kvistborg, P., Shu, C. J., Heemskerk, B., Fankhauser, M., Thrue, C. A., Toebes, M., van Rooij, N., Linnemann, C., van Buuren, M. M., Urbanus, J. H. M., et al. (2012) · OncoImmunology · doi:10.4161/onci.18851 · Cited by 178 · see citing works

Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients

Ellebæk, E., Iversen, T. Z., Junker, N., Donia, M., Engell-Noerregaard, L., Met, Ö., Hölmich, L. R., Andersen, R. S., Hadrup, S. R., Andersen, M. H., et al. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-169 · Cited by 172 · see citing works

T cell mediated immunity to influenza: mechanisms of viral control

Gruta, N. L. L., & Turner, S. J. (2014) · Trends in Immunology · doi:10.1016/j.it.2014.06.004 · Cited by 164 · see citing works

Anti-tumour immunity induces aberrant peptide presentation in melanoma

Bartok, O., Pataskar, A., Nagel, R., Laos, M., Goldfarb, E., Hayoun, D., Levy, R., Körner, P.-R., Kreuger, I. Z. M., Champagne, J., et al. (2020) · Nature · doi:10.1038/s41586-020-03054-1 · Cited by 162 · see citing works

Flow-cytometric analysis of rare antigen-specific T cells

Bacher, P., & Scheffold, A. (2013) · Cytometry Part A · doi:10.1002/cyto.a.22317 · Cited by 155 · see citing works

Dissection of T-cell Antigen Specificity in Human Melanoma

Andersen, R. S., Thrue, C. A., Junker, N., Lyngaa, R., Donia, M., Ellebæk, E., Svane, I. M., Schumacher, T. N., Straten, P. T., & Hadrup, S. R. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2614 · Cited by 158 · see citing works

Neoantigen prediction and computational perspectives towards clinical benefit: recommendations from the ESMO Precision Medicine Working Group

Mattos‐Arruda, L. D., Vázquez, M., Finotello, F., Lepore, R., Porta, E., Hundal, J., Amengual-Rigo, P., Ng, C. K. Y., Valencia, A., Carrillo, J., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.05.008 · Cited by 159 · see citing works

T cell antigen discovery

Joglekar, A. V., & Li, G. (2020) · Nature Methods · doi:10.1038/s41592-020-0867-z · Cited by 150 · see citing works

Tryptophan depletion results in tryptophan-to-phenylalanine substitutants

Pataskar, A., Champagne, J., Nagel, R., Kenski, J. C. N., Laos, M., Michaux, J., Pak, H. S., Bleijerveld, O. B., Mordente, K., Navarro, J. M., et al. (2022) · Nature · doi:10.1038/s41586-022-04499-2 · Cited by 146 · see citing works

Spectral Flow Cytometry

Nolan, J. P., & Condello, D. (2013) · Current Protocols in Cytometry · doi:10.1002/0471142956.cy0127s63 · Cited by 149 · see citing works

Exploiting Tumor Neoantigens to Target Cancer Evolution: Current Challenges and Promising Therapeutic Approaches

Gupta, R. G., Li, F., Roszik, J., & Lizee, G. A. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1575 · Cited by 144 · see citing works

Immunocytokines for cancer treatment: past, present and future

Neri, D., & Sondel, P. M. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2016.03.006 · Cited by 138 · see citing works

More tricks with tetramers: a practical guide to staining T cells with peptide– MHC multimers

Dolton, G. M., Tungatt, K., Lloyd, A., Bianchi, V., Theaker, S. M., Trimby, A., Holland, C. J., Donia, M., Godkin, A. J., Cole, D. K., et al. (2015) · Immunology · doi:10.1111/imm.12499 · Cited by 137 · see citing works

Determinants for Neoantigen Identification

García-Garijo, A., Fajardo, C. A., & Gros, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01392 · Cited by 136 · see citing works

Beyond model antigens: high-dimensional methods for the analysis of antigen-specific T cells

Newell, E. W., & Davis, M. M. (2014) · Nature Biotechnology · doi:10.1038/nbt.2783 · Cited by 129 · see citing works

Parallel detection of antigen-specific T cell responses by combinatorial encoding of MHC multimers

Andersen, R. S., Kvistborg, P., Frøsig, T. M., Pedersen, N. W., Lyngaa, R., Bakker, A., Shu, C. J., Straten, P. T., Schumacher, T. N., & Hadrup, S. R. (2012) · Nature Protocols · doi:10.1038/nprot.2012.037 · Cited by 132 · see citing works

Tumor‐infiltrating lymphocytes for the treatment of metastatic cancer

Foppen, M. H. G., Donia, M., Svane, I. M., & Haanen, J. B. A. G. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.10.018 · Cited by 130 · see citing works

Interrogating the repertoire: broadening the scope of peptide–MHC multimer analysis

Davis, M. M., Altman, J. D., & Newell, E. W. (2011) · Nature Reviews Immunology · doi:10.1038/nri3020 · Cited by 124 · see citing works

Identification and characterization of a SARS-CoV-2 specific CD8+ T cell response with immunodominant features

Gangaev, A., Ketelaars, S. L. C., Isaeva, O. I., Patiwael, S., Dopler, A., Hoefakker, K., De Biasi, S., Gibellini, L., Mussini, C., Guaraldi, G., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22811-y · Cited by 111 · see citing works

Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial

Ellebæk, E., Engell-Noerregaard, L., Iversen, T. Z., Frøsig, T. M., Ahmad, S. M., Hadrup, S. R., Andersen, M. H., & Svane, I. M. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1242-4 · Cited by 118 · see citing works

NetTCR: sequence-based prediction of TCR binding to peptide-MHC complexes using convolutional neural networksPreprint

Jurtz, V. I., Jessen, L. E., Bentzen, A. K., Jespersen, M. C., Mahajan, S., Vita, R., Jensen, K. K., Marcatili, P., Hadrup, S. R., Peters, B., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/433706 · Cited by 118 · see citing works

Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells

Fehlings, M., Simoni, Y., Penny, H. L., Becht, É., Loh, C. Y., Gubin, M. M., Ward, J. P., Wong, S. C., Schreiber, R. D., & Newell, E. W. (2017) · Nature Communications · doi:10.1038/s41467-017-00627-z · Cited by 112 · see citing works

Induction of neoantigen-reactive T cells from healthy donors

Ali, M., Földvári, Z., Giannakopoulou, E., Böschen, M.-L., Strønen, E., Yang, W., Toebes, M., Schubert, B., Kohlbacher, O., Schumacher, T. N., et al. (2019) · Nature Protocols · doi:10.1038/s41596-019-0170-6 · Cited by 108 · see citing works

CD86+ Antigen-Presenting B Cells Are Increased in Cancer, Localize in Tertiary Lymphoid Structures, and Induce Specific T-cell Responses

Wennhold, K., Thelen, M., Lehmann, J. M., Schran, S., Preugszat, E., Garcia-Marquez, M. A., Lechner, A., Shimabukuro‐Vornhagen, A., Ercanoglu, M. S., Klein, F., et al. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0949 · Cited by 107 · see citing works

Characterization and Comparison of ‘Standard’ and ‘Young’ Tumour‐Infiltrating Lymphocytes for Adoptive Cell Therapy at a Danish Translational Research Institution

Donia, M., Junker, N., Ellebæk, E., Andersen, M. H., Straten, P. T., & Svane, I. M. (2011) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2011.02640.x · Cited by 106 · see citing works

Machine learning methods and harmonized datasets improve immunogenic neoantigen prediction

Müller, M., Huber, F., Arnaud, M., Kraemer, A. I., Altimiras, E. R., Michaux, J., Taillandier-Coindard, M., Chiffelle, J., Murgues, B., Gehret, T., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.09.002 · Cited by 111 · see citing works

The Human Leukocyte Antigen–presented Ligandome of B Lymphocytes

Hassan, C., Kester, M. G. D., de Ru, A. H., Hombrink, P., Drijfhout, J. W., Nijveen, H., Leunissen, J. A. M., Heemskerk, M. H. M., Falkenburg, J. H. F., & van Veelen, P. A. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.024810 · Cited by 104 · see citing works

Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes

Poran, A., Harjanto, D., Malloy, M., Arieta, C. M., Rothenberg, D. A., Lenkala, D., van Buuren, M. M., Addona, T. A., Rooney, M. S., Srinivasan, L., et al. (2020) · Genome Medicine · doi:10.1186/s13073-020-00767-w · Cited by 102 · see citing works

MHC‐Peptide Tetramers to Visualize Antigen‐Specific T Cells

Altman, J. D., & Davis, M. M. (2016) · Current Protocols in Immunology · doi:10.1002/cpim.14 · Cited by 99 · see citing works

Vaccines and the Future of Human Immunology

Germain, R. N. (2010) · Immunity · doi:10.1016/j.immuni.2010.09.014 · Cited by 100 · see citing works

Heterotypic immunity against vaccinia virus in an HLA-B*07:02 transgenic mousepox infection model

Kumar, A., Suryadevara, N., Wolf, K. J., Wilson, J. T., DiPaolo, R. J., Brien, J. D., & Joyce, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-69897-w · Cited by 100 · see citing works

T-cell Responses to Oncogenic Merkel Cell Polyomavirus Proteins Distinguish Patients with Merkel Cell Carcinoma from Healthy Donors

Lyngaa, R., Pedersen, N. W., Schrama, D., Thrue, C. A., Ibrani, D., Met, Ö., Straten, P. T., Nghiem, P., Becker, J. C., & Hadrup, S. R. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2697 · Cited by 100 · see citing works

Mass cytometry: a powerful tool for dissecting the immune landscape

Simoni, Y., Chng, M. H. Y., Li, S., Fehlings, M., & Newell, E. W. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.03.023 · Cited by 97 · see citing works

Empty peptide-receptive MHC class I molecules for efficient detection of antigen-specific T cells

Saini, S. K., Tamhane, T., Anjanappa, R., Saikia, A., Ramskov, S., Donia, M., Svane, I. M., Jakobsen, S. N., García-Alai, M., Zacharias, M., et al. (2019) · Science Immunology · doi:10.1126/sciimmunol.aau9039 · Cited by 96 · see citing works

T cell receptor fingerprinting enables in-depth characterization of the interactions governing recognition of peptide–MHC complexes

Bentzen, A. K., Such, L., Jensen, K. K., Marquard, A. M., Jessen, L. E., Miller, N. J., Church, C. D., Lyngaa, R., Koelle, D. M., Becker, J. C., et al. (2018) · Nature Biotechnology · doi:10.1038/nbt.4303 · Cited by 94 · see citing works

Vaccination with LAG-3Ig (IMP321) and Peptides Induces Specific CD4 and CD8 T-Cell Responses in Metastatic Melanoma Patients—Report of a Phase I/IIa Clinical Trial

Legat, A., Hajjami, H. M.-E., Baumgaertner, P., Cagnon, L., Maillard, S. A., Geldhof, C., Iancu, E. M., Lebon, L., Guillaume, P., Dojcinovic, D., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1212 · Cited by 93 · see citing works

Detection, phenotyping, and quantification of antigen-specific T cells using a peptide-MHC dodecamer

Huang, J., Zeng, X., Sigal, N., Lund, P. J., Su, L. F., Huang, H., Chien, Y., & Davis, M. M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602488113 · Cited by 90 · see citing works

Personalized T cell-mediated cancer immunotherapy: progress and challenges

Bethune, M. T., & Joglekar, A. V. (2017) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.03.024 · Cited by 90 · see citing works

Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1 blockade might predict therapy outcome in metastatic urothelial carcinoma

Holm, J. S., Funt, S. A., Borch, A., Munk, K. K., Bjerregaard, A.-M., Reading, J. L., Maher, C. A., Regazzi, A. M., Wong, P., Al‐Ahmadie, H. A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29342-0 · Cited by 87 · see citing works

5-Azacytidine treatment sensitizes tumor cells to T-cell mediated cytotoxicity and modulates NK cells in patients with myeloid malignancies

Gang, A. O., Frøsig, T. M., Brimnes, M. K., Lyngaa, R., Treppendahl, M. B., Grønbæk, K., Dufva, I. H., Straten, P. T., & Hadrup, S. R. (2014) · Blood Cancer Journal · doi:10.1038/bcj.2014.14 · Cited by 86 · see citing works

Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial

Trepiakas, R., Berntsen, A., Hadrup, S. R., Bjørn, J., Geertsen, P. F., Straten, P. T., Andersen, M. H., Pedersen, A. E., Soleimani, A. H., Lorentzen, T., et al. (2010) · Cytotherapy · doi:10.3109/14653241003774045 · Cited by 81 · see citing works

The future of biology in driving the field of hyperthermia

Dewhirst, M. W., Lee, C.-T., & Ashcraft, K. A. (2016) · International Journal of Hyperthermia · doi:10.3109/02656736.2015.1091093 · Cited by 81 · see citing works

Development of Adoptive Cell Therapy for Cancer: A Clinical Perspective

Hawkins, R. E., Gilham, D. E., Debets, R., Eshhar, Z., Taylor, N. N., Abken, H., & Schumacher, T. N. (2010) · Human Gene Therapy · doi:10.1089/hum.2010.086 · Cited by 79 · see citing works

Discovering naturally processed antigenic determinants that confer protective T cell immunity

Gilchuk, P., Spencer, C. T., Conant, S. B., Hill, T. M., Gray, J. J., Niu, X., Zheng, M., Erickson, J. J., Boyd, K. L., McAfee, K. J., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67388 · Cited by 74 · see citing works

Immunodiagnosis of Tuberculosis: a Dynamic View of Biomarker Discovery

Kunnath-Velayudhan, S., & Gennaro, M. L. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00014-11 · Cited by 74 · see citing works

Viral based vaccine TG4010 induces broadening of specific immune response and improves outcome in advanced NSCLC

Tosch, C., Bastien, B., Barraud, L., Grellier, B., Nourtier, V., Gantzer, M., Limacher, J. M., Quéméneur, É., Bendjama, K., & Préville, X. (2017) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-017-0274-x · Cited by 73 · see citing works

Efficient ex vivo analysis of CD4+ T-cell responses using combinatorial HLA class II tetramer staining

Uchtenhagen, H., Rims, C. R., Blahnik, G., Chow, I., Kwok, W. W., Buckner, J. H., & James, E. A. (2016) · Nature Communications · doi:10.1038/ncomms12614 · Cited by 71 · see citing works

Evolution of MHC-based technologies used for detection of antigen-responsive T cells

Bentzen, A. K., & Hadrup, S. R. (2017) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-017-1971-5 · Cited by 69 · see citing works

Systematic discovery and validation of T cell targets directed against oncogenic KRAS mutations

Choi, J., Goulding, S. P., Conn, B. P., McGann, C. D., Dietze, J. L., Kohler, J., Lenkala, D., Boudot, A. J., Rothenberg, D., Turcott, P. J., et al. (2021) · Cell Reports Methods · doi:10.1016/j.crmeth.2021.100084 · Cited by 67 · see citing works

Recent advances and future of immunotherapy for glioblastoma

Kamran, N., Calinescu, A., Candolfi, M., Chandran, M., Mineharu, Y., Asad, A. S., Koschmann, C. J., Núñez, F. J., Lowenstein, P. R., & Castro, M. G. (2016) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2016.1212012 · Cited by 64 · see citing works

Nanoscale organization of two-dimensional multimeric pMHC reagents with DNA origami for CD8+ T cell detection

Sun, Y., Lü, Y., Sun, J., Xiao, M., Lai, W., Song, G., Li, L., Fan, C., & Pei, H. (2022) · Nature Communications · doi:10.1038/s41467-022-31684-8 · Cited by 64 · see citing works

TCR repertoires of intratumoral T‐cell subsets

Linnemann, C., Mezzadra, R., & Schumacher, T. N. (2013) · Immunological Reviews · doi:10.1111/imr.12140 · Cited by 63 · see citing works

A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike

Claireaux, M., Caniels, T., de Gast, M., Han, J., Guerra, D., Kerster, G., van Schaik, B. V., Jongejan, A., Schriek, A., Grobben, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32232-0 · Cited by 57 · see citing works

Generation of Peptide MHC Class I Monomers and Multimers Through Ligand Exchange

Toebes, M., Rodenko, B., Ovaa, H., & Schumacher, T. N. (2009) · Current Protocols in Immunology · doi:10.1002/0471142735.im1816s87 · Cited by 60 · see citing works

The Importance of Being Presented: Target Validation by Immunopeptidomics for Epitope-Specific Immunotherapies

Becker, J. P., & Riemer, A. B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.883989 · Cited by 56 · see citing works

Discovery of low-affinity preproinsulin epitopes and detection of autoreactive CD8 T-cells using combinatorial MHC multimers

Unger, W. W. J., Velthuis, J. H. L., Abreu, J. R. F., Laban, S., Quinten, E., Kester, M. G. D., Hadrup, S. R., Bakker, A., Duinkerken, G., Mulder, A., et al. (2011) · Journal of Autoimmunity · doi:10.1016/j.jaut.2011.05.012 · Cited by 56 · see citing works

Conditional ligands for A sian HLA variants facilitate the definition of CD 8+ T ‐cell responses in acute and chronic viral diseases

Chang, C. X. L., Tan, A. T., Or, M. Y., Toh, K. Y., Lim, P. Y., Chia, A., Frøsig, T. M., Nadua, K. D., Oh, H. J., Leong, H. N., et al. (2012) · European Journal of Immunology · doi:10.1002/eji.201243088 · Cited by 55 · see citing works

Targeted therapy and immunotherapy in advanced melanoma: an evolving paradigm

Khattak, M. A., Fisher, R. A., Turajlic, S., & Larkin, J. (2012) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834012466280 · Cited by 52 · see citing works

A flexible MHC class I multimer loading system for large-scale detection of antigen-specific T cells

Luimstra, J. J., Garstka, M. A., Roex, M. C. J., Redeker, A., Janssen, G. M. C., van Veelen, P. A., Arens, R., Falkenburg, J. H. F., Neefjes, J., & Ovaa, H. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20180156 · Cited by 51 · see citing works

Achievements and challenges of adoptive T cell therapy with tumor-infiltrating or blood-derived lymphocytes for metastatic melanoma: what is needed to achieve standard of care?

Svane, I. M., & Verdegaal, E. M. E. (2014) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-014-1580-5 · Cited by 50 · see citing works

Addition of 10-Day Decitabine to Fludarabine/Total Body Irradiation Conditioning is Feasible and Induces Tumor-Associated Antigen-Specific T Cell Responses

Cruijsen, M. J., Hobo, W. A., van der Velden, W. J. F. M., Bremmers, M. E. J., Woestenenk, R., Bär, B., Falkenburg, J. H. F., Kester, M. G. D., Schaap, N. P., Jansen, J. H., et al. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.02.003 · Cited by 49 · see citing works

T-cell epitope mapping for the design of powerful vaccines

Ahmad, T. A., Eweida, A. E., & Sayed, L. H. E. (2016) · Vaccine Reports · doi:10.1016/j.vacrep.2016.07.002 · Cited by 48 · see citing works

Progress in Neoantigen Targeted Cancer Immunotherapies

Han, X., Ma, X., Li, Y., Wei, Y.-Q., Peng, Y., & Wei, X. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00728 · Cited by 48 · see citing works

Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics

Nagler, A., Kalaora, S., Barbolin, C., Gangaev, A., Ketelaars, S. L. C., Alon, M., Pai, J. A., Benedek, G., Yahalom-Ronen, Y., Noam Erez, A., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109305 · Cited by 46 · see citing works

CD8 T cell autoreactivity to preproinsulin epitopes with very low human leucocyte antigen class I binding affinity

Abreu, J., Martina, S., Stuart, A. A. V., Fillié, Y. E., Franken, K. L. M. C., Drijfhout, J. W., & Roep, B. O. (2012) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2012.04635.x · Cited by 47 · see citing works

Current tools for predicting cancer-specific T cell immunity

Gfeller, D., Bassani‐Sternberg, M., Schmidt, J., & Luescher, I. F. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1177691 · Cited by 47 · see citing works

Neoantigen-Specific Adoptive Cell Therapies for Cancer: Making T-Cell Products More Personal

Bianchi, V., Harari, A., & Coukos, G. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01215 · Cited by 47 · see citing works

Neoantigen immunogenicity landscapes and evolution of tumor ecosystems during immunotherapy with nivolumab

Alban, T. J., Riaz, N., Parthasarathy, P. B., Makarov, V., Kendall, S. M., Yoo, S., Shah, R., Weinhold, N., Srivastava, R. M., Ma, X., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03240-y · Cited by 47 · see citing works

Visible and near infrared fluorescence spectral flow cytometry

Nolan, J. P., Condello, D., Duggan, E., Naivar, M. A., & Novo, D. J. (2012) · Cytometry Part A · doi:10.1002/cyto.a.22241 · Cited by 45 · see citing works

Molecularly defined vaccines for cancer immunotherapy, and protective T cell immunity

Speiser, D. E., & Romero, P. J. (2010) · Seminars in Immunology · doi:10.1016/j.smim.2010.03.004 · Cited by 43 · see citing works

Parallel detection of antigen-specific T cell responses by combinatorial encoding of MHC multimers

Andersen, R. S., Kvistborg, P., Frøsig, T. M., Pedersen, N. W., Lyngaa, R., Bakker, A., Shu, C. J., Straten, P. T., Schumacher, T. N., & Hadrup, S. R. (2012) · Nature Protocols · doi:10.1038/nprot.2012.037 · Cited by 132 · see citing works

Simultaneous detection of many T-cell specificities using combinatorial tetramer staining

Newell, E. W., Klein, L. O., Yu, W., & Davis, M. M. (2009) · Nature Methods · doi:10.1038/nmeth.1344 · Cited by 182 · see citing works

MHC-based detection of antigen-specific CD8+ T cell responses

Hadrup, S. R., & Schumacher, T. N. (2010) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-010-0824-2 · Cited by 31 · see citing works

Parallel detection of antigen-specific T cell responses by combinatorial encoding of MHC

Kvistborg, P., Frøsig, T. M., Pedersen, N. W., Lyngaa, R., Bakker, A., Shu, C. J., Straten, P. T., Schumacher, T. N., & Hadrup, S. R. (2012)

FOCUSSED RESEARCH REVIEW MHC-based detection of antigen-speciWc CD8 + T cell responses

Reker, S., Ton, H., & Schumacher, N. (2013)